Free Trial
NASDAQ:ABVX

Abivax (ABVX) Stock Price, News & Analysis

Abivax logo
$70.83 +1.03 (+1.48%)
Closing price 07/30/2025 04:00 PM Eastern
Extended Trading
$69.60 -1.23 (-1.74%)
As of 04:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Abivax Stock (NASDAQ:ABVX)

Key Stats

Today's Range
$69.58
$71.84
50-Day Range
$5.67
$70.83
52-Week Range
$4.77
$72.90
Volume
1.36 million shs
Average Volume
2.96 million shs
Market Capitalization
$4.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$92.33
Consensus Rating
Buy

Company Overview

Abivax Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

ABVX MarketRank™: 

Abivax scored higher than 64% of companies evaluated by MarketBeat, and ranked 375th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Abivax has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Abivax has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Abivax's stock forecast and price target.
  • Earnings Growth

    Earnings for Abivax are expected to grow in the coming year, from ($2.83) to ($2.57) per share.

  • Price to Book Value per Share Ratio

    Abivax has a P/B Ratio of 102.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Abivax's valuation and earnings.
  • Percentage of Shares Shorted

    2.68% of the float of Abivax has been sold short.
  • Short Interest Ratio / Days to Cover

    Abivax has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Abivax has recently increased by 18.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Abivax does not currently pay a dividend.

  • Dividend Growth

    Abivax does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.68% of the float of Abivax has been sold short.
  • Short Interest Ratio / Days to Cover

    Abivax has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Abivax has recently increased by 18.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Abivax has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.04 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 34 news articles for Abivax this week, compared to 2 articles on an average week.
  • Search Interest

    29 people have searched for ABVX on MarketBeat in the last 30 days. This is an increase of 2,800% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Abivax to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Abivax insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    47.91% of the stock of Abivax is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Abivax's insider trading history.
Receive ABVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abivax and its competitors with MarketBeat's FREE daily newsletter.

ABVX Stock News Headlines

Abivax (NASDAQ:ABVX) Trading Up 5.2% on Analyst Upgrade
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Abivax Announces Closing of $747.5 Million Public Offering
FY2025 EPS Estimates for Abivax Cut by Leerink Partnrs
FY2025 EPS Estimates for Abivax Boosted by Lifesci Capital
See More Headlines

ABVX Stock Analysis - Frequently Asked Questions

Abivax's stock was trading at $7.32 at the beginning of 2025. Since then, ABVX shares have increased by 867.6% and is now trading at $70.83.

Abivax (ABVX) raised $217 million in an initial public offering (IPO) on Friday, October 20th 2023. The company issued 18,699,460 shares at a price of $11.60 per share.

Shares of ABVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abivax investors own include Adverum Biotechnologies (ADVM), APi Group (APG), Avino Silver & Gold Mines (ASM), Boot Barn (BOOT), G1 Therapeutics (GTHX), Howard Hughes (HHH) and KT (KT).

Company Calendar

Today
7/31/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABVX
Previous Symbol
NASDAQ:ABVX
CIK
1956827
Fax
N/A
Employees
61
Year Founded
N/A

Price Target and Rating

High Price Target
$112.00
Low Price Target
$71.00
Potential Upside/Downside
+30.4%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
1.29
Current Ratio
1.25
Quick Ratio
1.25

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
102.65

Miscellaneous

Outstanding Shares
63,470,000
Free Float
N/A
Market Cap
$4.50 billion
Optionable
Not Optionable
Beta
0.33
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ABVX) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners